Skip to Content

Sulfac 10% Side Effects

Generic Name: sulfacetamide sodium ophthalmic

Note: This page contains side effects data for the generic drug sulfacetamide sodium ophthalmic. It is possible that some of the dosage forms included below may not apply to the brand name Sulfac 10%.

For the Consumer

Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution, ophthalmic suspension

Side effects include:

Local irritation, transient stinging or burning.

For Healthcare Professionals

Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution

General

The side effects reported most often were local/conjunctival irritation, stinging, and burning.[Ref]

Ocular

Frequency not reported: Local/conjunctival irritation, stinging, burning, nonspecific conjunctivitis, conjunctival hyperemia, bacterial corneal ulcers, fungal corneal ulcers[Ref]

Hypersensitivity

At least 1 case of local hypersensitivity has been reported that progressed to a SLE-like fatal syndrome.[Ref]

Rare (less than 0.1%): Sensitivity reactions
Frequency not reported: Allergic reactions/hypersensitivity, local hypersensitivity progressing to fatal syndrome resembling systemic lupus erythematosus (SLE)[Ref]

Other

Frequency not reported: Secondary infections[Ref]

Dermatologic

Sulfonamides:
-Frequency not reported: Stevens-Johnson syndrome, toxic epidermal necrolysis[Ref]

Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).

Stevens-Johnson syndrome was reported in a patient with history of blistering drug reaction to an oral sulfonamide.[Ref]

Hematologic

Sulfonamides:
-Frequency not reported: Agranulocytosis, aplastic anemia, other blood dyscrasias[Ref]

Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]

Hepatic

Sulfonamides:
-Frequency not reported: Fulminant hepatic necrosis[Ref]

Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]

References

1. Cerner Multum, Inc. "Australian Product Information." O 0

2. "Product Information. Sulamyd Ophthalmic Solution (sodium sulfacetamide ophthalmic)." Schering Corporation, Kenilworth, NJ.

It is possible that some side effects of Sulfac 10% may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide